Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    18-November-2000      
Issue 219 Next Update - 14:00 UTC 08:00 EST    19-November-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya FDA Forces Firm To Stop Selling All Amygdalin/Laetrile Products

Christian Brothers Contracting Corporation Signs Consent Decree With FDA

The Food and Drug Administration announced that Christian Brothers Contracting Corporation and its President, Jason Vale, have signed a consent decree of permanent injunction in which it agreed to stop manufacturing, processing, and distributing its amygdalin products, also referred to as Laetrile, Vitamin B-17 or apricot kernels. The products were promoted for use in cancer therapy. The consent decree was entered on November 16 by United States District Court Judge John Gleeson in Brooklyn, New York.

Amygdalin is a glucoside found in the kernel or seeds of most fruits and is frequently referred to as "Laetrile" or "Vitamin B-17". While some proponents have recommended it for the treatment and control of cancer, these claims have never been approved by the Food and Drug Administration. There are no published clinical studies which demonstrate that laetrile is safe and effective and cancer patients who take it sometimes forgo conventional therapies to their detriment.

The government's action in this case follows prior inspections of defendants' facilities in New York and several undercover purchases from defendants which revealed that the amygdalin or Laetrile products were being promoted as a drug for the cure, mitigation, treatment and prevention of cancer. The government also alleged that defendants used Internet web sites to sell and market its amygdalin products. Despite warnings from FDA, Christian Brothers continued to distribute its laetrile products into interstate commerce.

The court had preliminarily enjoined the defendants from selling amygdalin on April 20, 2000. The consent decree signed by Christian Brothers and its president will ensure that defendants keep their commitment with the agency to permanently discontinue selling amygdalin products.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.